134 related articles for article (PubMed ID: 29046905)
61. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
[TBL] [Abstract][Full Text] [Related]
62. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
63. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
64. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
[TBL] [Abstract][Full Text] [Related]
65. Identification and gastrointestinal expression of Xenopus laevis FoxF2.
McLin VA; Shah R; Desai NP; Jamrich M
Int J Dev Biol; 2010; 54(5):919-24. PubMed ID: 20336609
[TBL] [Abstract][Full Text] [Related]
66. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
[TBL] [Abstract][Full Text] [Related]
67. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.
Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X
Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477
[TBL] [Abstract][Full Text] [Related]
68. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F
Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092
[TBL] [Abstract][Full Text] [Related]
69. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
70. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
71. FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1.
Wang S; Yan S; Zhu S; Zhao Y; Yan J; Xiao Z; Bi J; Qiu J; Zhang D; Hong Z; Zhang L; Huang C; Li T; Liang L; Liao W; Jiao H; Ding Y; Ye Y
Neoplasia; 2018 Oct; 20(10):996-1007. PubMed ID: 30189360
[TBL] [Abstract][Full Text] [Related]
72. Foxf2 Is Required for Brain Pericyte Differentiation and Development and Maintenance of the Blood-Brain Barrier.
Reyahi A; Nik AM; Ghiami M; Gritli-Linde A; Pontén F; Johansson BR; Carlsson P
Dev Cell; 2015 Jul; 34(1):19-32. PubMed ID: 26120030
[TBL] [Abstract][Full Text] [Related]
73. Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer.
Ryu JR; Ahuja S; Arnold CR; Potts KG; Mishra A; Yang Q; Sargurupremraj M; Mahoney DJ; Seshadri S; Debette S; Childs SJ
Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2121333119. PubMed ID: 35994645
[TBL] [Abstract][Full Text] [Related]
74. The Role of Forkhead Box Family in Bone Metabolism and Diseases.
Xu J; Wang K; Zhang Z; Xue D; Li W; Pan Z
Front Pharmacol; 2021; 12():772237. PubMed ID: 35153742
[TBL] [Abstract][Full Text] [Related]
75. Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies.
Kong X; Zhai J; Yan C; Song Y; Wang J; Bai X; Brown JAL; Fang Y
Front Oncol; 2019; 9():234. PubMed ID: 31214487
[TBL] [Abstract][Full Text] [Related]
76. The Debate on Cancer of the Breast.
Hospital (Lond 1886); 1898 Mar; 23(597):393-394. PubMed ID: 29833125
[No Abstract] [Full Text] [Related]
77. The Spectrum Theory in Breast Cancer Is Controversial.
Kayar R
Eur J Breast Health; 2017 Oct; 13(4):219-220. PubMed ID: 29082382
[No Abstract] [Full Text] [Related]
78. Unraveling the Molecular Puzzle: Exploring Gene Networks across Diverse EMT Status of Cell Lines.
Park H
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628965
[TBL] [Abstract][Full Text] [Related]
79. Characterization of the skin keloid microenvironment.
Zhang M; Chen H; Qian H; Wang C
Cell Commun Signal; 2023 Aug; 21(1):207. PubMed ID: 37587491
[TBL] [Abstract][Full Text] [Related]
80. Global gene network exploration based on explainable artificial intelligence approach.
Park H; Maruhashi K; Yamaguchi R; Imoto S; Miyano S
PLoS One; 2020; 15(11):e0241508. PubMed ID: 33156825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
